Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics
- 30 April 1997
- journal article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 31 (2) , 233-256
- https://doi.org/10.1016/s0022-3956(96)00041-6
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjectsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1995
- G proteins (Gi, Go) in the medial temporal lobe in schizophrenia: preliminary report of a neurochemical correlate of structural changeJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- (3H]MK-801 binding sites in postmortem brain regions of schizophrenic patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenicsArchiv Fur Psychiatrie Und Nervenkrankheiten, 1989
- A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey: I. Convergence in the entorhinal, prorhinal, and perirhinal corticesJournal of Comparative Neurology, 1988
- The entorhinal cortex of the monkey: III. Subcortical afferentsJournal of Comparative Neurology, 1987
- [3H]Muscimol binding sites increased in autopsied brains of chronic schizophrenicsLife Sciences, 1987
- Prenatal developmental disturbances in the limbic allocortex in schizophrenicsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
- Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patientsLife Sciences, 1985
- Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophreniaLife Sciences, 1983